The RSM has an extensive digital learning and online e-resources platform. As a member you'll enjoy free access to a wealth of online resources, including 5,000 subscription and open access e-journals, 2,000 e-books and 5 key medical databases, to support your clinical decision-making and research.
- Date and time Fri 29 May 2020 from 5:30pm to 9:00pm
- Location Royal Society of Medicine
- Organised by Obstetrics and Gynaecology
Please note this event has been cancelled due to the coronavirus pandemic, we apologise for any inconvenience.
The aim of this meeting is to provide an overview of the recent advances in obstetric and gynaecological research and discuss future academic priorities. The panel includes several UK academic leaders who are uniquely placed to provide the audience with a comprehensive summary of recent academic developments and directions for future research.
Fetal medicine is one of the most dynamic and fastest developing area of clinical practice within obstetrics and gynaecology. The research output of fetal medicine specialists is immense and participants will have the opportunity to learn about the results of recent key clinical studies in this area and future research priorities.
Delegates will receive an update regarding multi-centre research in the diagnosis and management of early pregnancy complications, such as how the hormone progesterone can reduce the chances of women having a miscarriage. Delegates will also have the chance to learn about new innovative surgical techniques in this area medicine; for example, repairing the spines of unborn babies just weeks before they're born.
There will also be discussions on the treatment of cancer which is challenging for women and their clinicians and the prevention remains a key objective in the effort to reduce cancer-related morbidity and mortality. We will hear about novel developments in this area of research and its potential impact on clinical practice in the UK and Internationally. For example, the recent research at Queen's university to develop a test that may be able to detect ovarian cancer up to two years earlier than current approaches.
Join in the conversation online
Follow us on Twitter: @RoySocMed